These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 4457225)

  • 1. Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
    Côté P; Polumbo RA; Harrison DC
    Cardiovasc Res; 1974 Nov; 8(6):721-30. PubMed ID: 4457225
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential inotropic--chronotropic action of thyronamine.
    Boissier JR; Giudicelli JF; Larno S; Advenier C
    Eur J Pharmacol; 1973 May; 22(2):141-9. PubMed ID: 4715216
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodynamic responses to ethylphenylephrine (Effortil) during halothane-induced myocardial depression in the dog.
    Tarnow J; Brückner JB; Eberlein HJ; Patschke D; Schmicke P; Weymar A
    Acta Anaesthesiol Scand; 1973; 17(3):184-9. PubMed ID: 4754119
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of adrenergic blockade on cardiovascular responses to increased airway pressure.
    Feisal KA; Abboud FM; Eckstein JW
    Am J Physiol; 1967 Jul; 213(1):127-33. PubMed ID: 6027908
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of inotropic substances on the heart dynamics and peripheral blood circulation].
    Schüren KP; Buschmann J; Meyer V; Schröder R
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():206-13. PubMed ID: 4899541
    [No Abstract]   [Full Text] [Related]  

  • 6. A new anorexic agent, WY-5244: cardiovascular actions and influence on sympathomimetic amines.
    Baum T; Gluckman MI
    J Pharmacol Exp Ther; 1967 Jul; 157(1):32-41. PubMed ID: 4382099
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular effects of dopamine in the anaesthetized dog.
    Sampson RG; Scroop GC; Louis WJ
    Clin Exp Pharmacol Physiol; 1974; 1(1):3-12. PubMed ID: 4457265
    [No Abstract]   [Full Text] [Related]  

  • 8. The cardiovascular activity of 2-amino-5-(3,4-dichlorophenoxymethyl)-2-oxazoline (APMO).
    Abdallah AH; White HD
    Toxicol Appl Pharmacol; 1973 Dec; 26(4):513-22. PubMed ID: 4149198
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular effects of dimethophrine in the dog].
    Monguzzi G; Romano A; Scrollini F
    G Ital Cardiol; 1973; 3(1):102-11. PubMed ID: 4695015
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular effects of sustained norepinephrine infusions in dogs. IV. Previous treatment with adrenergic blocking agents.
    Moss AJ; Schenk EA
    Circ Res; 1970 Dec; 27(6):1013-22. PubMed ID: 4395090
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular effects of guanazole.
    Vick JA; Herman EH
    Toxicol Appl Pharmacol; 1970 Jan; 16(1):108-19. PubMed ID: 5416741
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary and systemic circulatory effects and -adrenergic selectivity of hexoprenaline, salbutamol, oxyfedrine, and isoproterenol.
    Turnheim K; Kraupp O
    Eur J Pharmacol; 1971 Jul; 15(2):231-9. PubMed ID: 5153847
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
    Jewitt D; Birkhead J; Mitchell A; Dollery C
    Lancet; 1974 Aug; 2(7877):363-7. PubMed ID: 4136593
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of cardiovascular responses by propranolol.
    Vogel JH; Blount SG
    Br Heart J; 1967 May; 29(3):310-6. PubMed ID: 6023724
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular responses to catecholamine of the sinus node artery of the dog.
    Chiba S; Hashimoto K
    Jpn J Physiol; 1970 Feb; 20(1):112-7. PubMed ID: 5311128
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of the sympathomimetic action of cyclohexylamine and hexylamine: release of catecholamines from nerve endings.
    Wechsler AS; Epstein SE; Glick G
    J Pharmacol Exp Ther; 1969 Nov; 170(1):62-71. PubMed ID: 5351007
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
    Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Cardiovascular effects of dobutamine, a selective inotropic catecholamine.
    Jewitt D; Birkhead J; Mitchell A; Dollery C
    Br Heart J; 1974 Oct; 36(10):1034-5. PubMed ID: 4433436
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular effects of chloralose in catecholamine-depleted or receptor-blocked dogs.
    Charney AN; Bass BG; Buckley NM
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):397-405. PubMed ID: 5473799
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of beta-receptor blockade on the systemic and coronary hemodynamic response to an increasing ventricular rate in the unanesthetized dog.
    Cobb FR; Bache RJ; Ebert PA; Rembert JC; Greenfield JC
    Circ Res; 1969 Sep; 25(3):331-41. PubMed ID: 5822520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.